초록

A thermopile-based detector for monitoring and/or controlling semiconductor processes, and a method of monitoring and/or controlling semiconductor processes using thermopile-based sensing of conditions in and/or affecting such processes.

대표청구항 ▼

A thermopile-based detector for monitoring and/or controlling semiconductor processes, and a method of monitoring and/or controlling semiconductor processes using thermopile-based sensing of conditions in and/or affecting such processes. tive cell growth-promoting concentrations of α-ketoglutarate,

A thermopile-based detector for monitoring and/or controlling semiconductor processes, and a method of monitoring and/or controlling semiconductor processes using thermopile-based sensing of conditions in and/or affecting such processes. tive cell growth-promoting concentrations of α-ketoglutarate, insulin, transferrin, selenium, bovine serum albumin, linoleic acid, ceruloplasmin, cholesterol, phosphatidylethanolamine, α-tocopherol acid succinate, reduced glutathione, taurine, triiodothyronine, hydrocortisone, parathyroid hormone, L-ascorbic acid 2-sulfate, β-glycerophosphate, platelet-derived growth factor (PDGF), epidermal growth factor (EGF) and basic fibroblast growth factor (bEGF) and at least one morphogenetic protein selected from the group consisting of cartilage-derived morphogenetic proteins and bone morphogenetic proteins, whereby a cartilaginous phenotype is maintained in said chondrocytes; and implanting said chondrocytes into said surface defect. 3. The method of claim 1 or 2, wherein two basal cell culture media are selected and mixed in equal proportion and wherein said basal cell culture media are selected from the group consisting of Ham's F-12, Dulbecco's modified Eagle's medium (DMEM), Essential modified Eagle's medium (EMEM) and RPMI-1640. 4. The method of claim 1 or 2, wherein said morphogenetic protein is cartilage-derived morphogenetic protein and is selected from the group consisting of CDMP-1 and CDMP-2. 5. The method of claim 1 or 2, wherein said morphogenetic protein is bone morphogenetic protein and is selected from the group consisting of OP-1, BMP-2, BMP-3, BMP-4, BMP-5 and BMP-6. 6. The method of claim 1 or 2, wherein the concentration of α-ketoglutarate is about 1×10-4M. 7. The method of claim 1 or 2, wherein the concentration of ceruloplasmin is about 0.25 U/ml. 8. The method of claim 1 or 2, wherein the concentration of cholesterol is about 5 μg/ml. 9. The method of claim 1 or 2, wherein the concentration of phosphatidyl-ethanolamine is about 2 μg/ml. 10. The method of claim 1 or 2, wherein the concentration of α-tocopherol acid succinate is about 9×10-7M. 11. The method of claim 1 or 2, wherein the concentration of reduced glutathione is about 10 μg/ml. 12. The method of claim 1 or 2, wherein the concentration of taurine is about 1.25 μg/ml. 13. The method of claim 1 or 2, wherein the concentration of triiodothyronine is about 1.6×10-9M. 14. The method of claim 1 or 2, wherein the concentration of hydrocortisone is about 1×10-9M. 15. The method of claim 1 or 2, wherein the concentration of parathyroid hormone is about 5×10-10M. 16. The method of claim 1 or 2, wherein the concentration of L-ascorbic acid 2-sulfate is about 50 μg/ml. 17. The method of claim 1 or 2, wherein the concentration of PDGF is about 4 ng/ml. 18. The method of claim 1 or 2, wherein the concentration of EGF is about 10 ng/ml. 19. The method of claim 1 or 2, wherein the concentration of bFGF is about 10 ng/ml. 20. The method of claim 2, wherein said isolating chondrocytes step comprises digestion of said cartilage with collagenase.